Announced Mon, 9 Feb · 14:28 IST

Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Pursuance to Regulation ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Wardwizard Healthcare Ltd (formerly Ayoki Mercantile Limited, BSE: 512063) has informed BSE that its Board of Directors will meet on Thursday, February 12, 2026. The main agenda item is the approval of unaudited standalone financial results for the third quarter and nine months ended December 31, 2025 (FY25-26). The company also confirmed that the trading window for designated persons has been closed from January 1, 2026, and will remain closed until 48 hours after the results are declared — i.e., until February 14, 2026. The filing is made under Regulation 29 of SEBI Listing Obligations and Disclosure Requirements. No financial figures, projections, or specific business items have been disclosed in this intimation.

Likely market impact

This is a routine compliance filing and does not contain any new financial data. Shareholders should watch for the actual Q3 FY26 results announcement, which is expected after the February 12 board meeting. The closed trading window restricts insider trading until results are published.